Simultaneous binding of the anti-cancer IgM monoclonal antibody PAT-SM6 to low density lipoproteins and GRP78.

The tumour-derived monoclonal IgM antibody PAT-SM6 specifically kills malignant cells by an apoptotic mechanism linked to the excessive uptake of plasma lipids. The mechanism is postulated to occur via the multi-point attachment of PAT-SM6 to the unfolded protein response regulator GRP78, located on...

Full description

Bibliographic Details
Main Authors: Zachary Rosenes, Yee-Foong Mok, Shuo Yang, Michael D W Griffin, Terrence D Mulhern, Danny M Hatters, Frank Hensel, Geoffrey J Howlett
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3631193?pdf=render
_version_ 1818537648832118784
author Zachary Rosenes
Yee-Foong Mok
Shuo Yang
Michael D W Griffin
Terrence D Mulhern
Danny M Hatters
Frank Hensel
Geoffrey J Howlett
author_facet Zachary Rosenes
Yee-Foong Mok
Shuo Yang
Michael D W Griffin
Terrence D Mulhern
Danny M Hatters
Frank Hensel
Geoffrey J Howlett
author_sort Zachary Rosenes
collection DOAJ
description The tumour-derived monoclonal IgM antibody PAT-SM6 specifically kills malignant cells by an apoptotic mechanism linked to the excessive uptake of plasma lipids. The mechanism is postulated to occur via the multi-point attachment of PAT-SM6 to the unfolded protein response regulator GRP78, located on the surface of tumour cells, coupled to the simultaneous binding of plasma low density lipoprotein (LDL). We prepared and characterised LDL and oxidized LDL using sedimentation velocity and small-angle X-ray scattering (SAXS) analysis. Enzyme-linked immunosorbent (ELISA) techniques indicated apparent dissociation constants of approximately 20 nM for the binding of LDL or oxidized LDL to PAT-SM6. ELISA experiments showed cross competition with LDL inhibiting PAT-SM6 binding to immobilised GRP78, while, in the reverse experiment, GRP78 inhibited PAT-SM6 binding to immobilized LDL. In contrast to the results of the ELISA experiments, sedimentation velocity experiments indicated relatively weak interactions between LDL and PAT-SM6, suggesting immunoabsorbance to the microtiter plate is driven by an avidity-based binding mechanism. The importance of avidity and the multipoint attachment of antigens to PAT-SM6 was further investigated using antigen-coated polystyrene beads. Absorption of GRP78 or LDL to polystyrene microspheres led to an increase in the inhibition of PAT-SM6 binding to microtiter plates coated with GRP78 or LDL, respectively. These results support the hypothesis that the biological action of PAT-SM6 in tumour cell apoptosis depends on the multivalent nature of PAT-SM6 and the ability to interact simultaneously with LDL and multiple GRP78 molecules clustered on the tumour cell surface.
first_indexed 2024-12-11T18:53:28Z
format Article
id doaj.art-ae81aa276e2b400a843d246b136efd44
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-11T18:53:28Z
publishDate 2013-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-ae81aa276e2b400a843d246b136efd442022-12-22T00:54:14ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-0184e6123910.1371/journal.pone.0061239Simultaneous binding of the anti-cancer IgM monoclonal antibody PAT-SM6 to low density lipoproteins and GRP78.Zachary RosenesYee-Foong MokShuo YangMichael D W GriffinTerrence D MulhernDanny M HattersFrank HenselGeoffrey J HowlettThe tumour-derived monoclonal IgM antibody PAT-SM6 specifically kills malignant cells by an apoptotic mechanism linked to the excessive uptake of plasma lipids. The mechanism is postulated to occur via the multi-point attachment of PAT-SM6 to the unfolded protein response regulator GRP78, located on the surface of tumour cells, coupled to the simultaneous binding of plasma low density lipoprotein (LDL). We prepared and characterised LDL and oxidized LDL using sedimentation velocity and small-angle X-ray scattering (SAXS) analysis. Enzyme-linked immunosorbent (ELISA) techniques indicated apparent dissociation constants of approximately 20 nM for the binding of LDL or oxidized LDL to PAT-SM6. ELISA experiments showed cross competition with LDL inhibiting PAT-SM6 binding to immobilised GRP78, while, in the reverse experiment, GRP78 inhibited PAT-SM6 binding to immobilized LDL. In contrast to the results of the ELISA experiments, sedimentation velocity experiments indicated relatively weak interactions between LDL and PAT-SM6, suggesting immunoabsorbance to the microtiter plate is driven by an avidity-based binding mechanism. The importance of avidity and the multipoint attachment of antigens to PAT-SM6 was further investigated using antigen-coated polystyrene beads. Absorption of GRP78 or LDL to polystyrene microspheres led to an increase in the inhibition of PAT-SM6 binding to microtiter plates coated with GRP78 or LDL, respectively. These results support the hypothesis that the biological action of PAT-SM6 in tumour cell apoptosis depends on the multivalent nature of PAT-SM6 and the ability to interact simultaneously with LDL and multiple GRP78 molecules clustered on the tumour cell surface.http://europepmc.org/articles/PMC3631193?pdf=render
spellingShingle Zachary Rosenes
Yee-Foong Mok
Shuo Yang
Michael D W Griffin
Terrence D Mulhern
Danny M Hatters
Frank Hensel
Geoffrey J Howlett
Simultaneous binding of the anti-cancer IgM monoclonal antibody PAT-SM6 to low density lipoproteins and GRP78.
PLoS ONE
title Simultaneous binding of the anti-cancer IgM monoclonal antibody PAT-SM6 to low density lipoproteins and GRP78.
title_full Simultaneous binding of the anti-cancer IgM monoclonal antibody PAT-SM6 to low density lipoproteins and GRP78.
title_fullStr Simultaneous binding of the anti-cancer IgM monoclonal antibody PAT-SM6 to low density lipoproteins and GRP78.
title_full_unstemmed Simultaneous binding of the anti-cancer IgM monoclonal antibody PAT-SM6 to low density lipoproteins and GRP78.
title_short Simultaneous binding of the anti-cancer IgM monoclonal antibody PAT-SM6 to low density lipoproteins and GRP78.
title_sort simultaneous binding of the anti cancer igm monoclonal antibody pat sm6 to low density lipoproteins and grp78
url http://europepmc.org/articles/PMC3631193?pdf=render
work_keys_str_mv AT zacharyrosenes simultaneousbindingoftheanticancerigmmonoclonalantibodypatsm6tolowdensitylipoproteinsandgrp78
AT yeefoongmok simultaneousbindingoftheanticancerigmmonoclonalantibodypatsm6tolowdensitylipoproteinsandgrp78
AT shuoyang simultaneousbindingoftheanticancerigmmonoclonalantibodypatsm6tolowdensitylipoproteinsandgrp78
AT michaeldwgriffin simultaneousbindingoftheanticancerigmmonoclonalantibodypatsm6tolowdensitylipoproteinsandgrp78
AT terrencedmulhern simultaneousbindingoftheanticancerigmmonoclonalantibodypatsm6tolowdensitylipoproteinsandgrp78
AT dannymhatters simultaneousbindingoftheanticancerigmmonoclonalantibodypatsm6tolowdensitylipoproteinsandgrp78
AT frankhensel simultaneousbindingoftheanticancerigmmonoclonalantibodypatsm6tolowdensitylipoproteinsandgrp78
AT geoffreyjhowlett simultaneousbindingoftheanticancerigmmonoclonalantibodypatsm6tolowdensitylipoproteinsandgrp78